The DOI matches its Crossref record; 40 of the 40 references it cites were found in a registry or an index.
Effects of Bacteriocins on Methicillin-Resistant Staphylococcus aureus Biofilm
Open accessAbstract
Control of biofilms formed by microbial pathogens is an important subject for medical researchers, since the development of biofilms on foreign-body surfaces often causes biofilm-associated infections in patients with indwelling medical devices. The present study examined the effects of different kinds of bacteriocins, which are ribosomally synthesized antimicrobial peptides produced by certain bacteria, on biofilms formed by a clinical isolate of methicillin-resistant Staphylococcus aureus (MRSA). The activities and modes of action of three bacteriocins with different structures (nisin A, lacticin Q, and nukacin ISK-1) were evaluated. Vancomycin, a glycopeptide antibiotic used in the treatment of MRSA infections, showed bactericidal activity against planktonic cells but not against biofilm cells. Among the tested bacteriocins, nisin A showed the highest bactericidal activity against both planktonic cells and biofilm cells. Lacticin Q also showed bactericidal activity against both planktonic cells and biofilm cells, but its activity against biofilm cells was significantly lower than that of nisin A. Nukacin ISK-1 showed bacteriostatic activity against planktonic cells and did not show bactericidal activity against biofilm cells. Mode-of-action studies indicated that pore formation leading to ATP efflux is important for the bactericidal activity against biofilm cells. Our results suggest that bacteriocins that form stable pores on biofilm cells are highly potent for the treatment of MRSA biofilm infections.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Bacterial Biofilms: A Common Cause of Persistent Infections
Costerton, J. W., Stewart, P. S., & Greenberg, E. P. (1999) · Science · doi:10.1126/science.284.5418.1318 · Cited by 12,167 · cited 7×
“effects of the peptides on membrane integrity, we measured the membrane potentials of the biofilm cells by using DiBAC4(3), a membrane-potential-sensitive probe (24) (Fig.”
BackgroundMethodInfluentialFlemming, H.-C., & Wingender, J. (2010) · Nature Reviews Microbiology · doi:10.1038/nrmicro2415 · Cited by 10,137
Bacteriocins: Developing innate immunity for food
Cotter, P. D., Hill, C., & Ross, R. P. (2005) · Nature Reviews Microbiology · doi:10.1038/nrmicro1273 · Cited by 2,380 · cited 1×
“Bacteriocins produced by Gram-positive bacteria are classified into two distinct categories: the lanthionine-containing bacteriocins (class I) and the non-lanthionine-containing bacteriocins (class II) (9).”
BackgroundBacteriocins—A viable alternative to antibiotics?
Cotter, P. D., Ross, R. P., & Hill, C. (2013) · Nature Reviews Microbiology · doi:10.1038/nrmicro2937 · Cited by 1,793
Biofilm Formation: A Clinically Relevant Microbiological Process
Donlan, R. M. (2001) · Clinical Infectious Diseases · doi:10.1086/322972 · Cited by 1,343
Use of the Cell Wall Precursor Lipid II by a Pore-Forming Peptide Antibiotic
Breukink, E., Wiedemann, I., Kraaij, C. V., Kuipers, O. P., Sahl, H.-G., & de Kruijff, B. (1999) · Science · doi:10.1126/science.286.5448.2361 · Cited by 814
Community-acquired meticillin-resistant Staphylococcus aureus: an emerging threat
Zetola, N., Francis, J. S., Nuermberger, E. L., & Bishai, W. R. (2005) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(05)70112-2 · Cited by 791 · cited 1×
“(MRSA) is a significant public health problem worldwide (22).”
BackgroundBiosynthesis and Mode of Action of Lantibiotics
Chatterjee, C., Paul, M., Xie, L., & van der Donk, W. A. (2005) · Chemical Reviews · doi:10.1021/cr030105v · Cited by 718
Horsburgh, M. J., Aish, J. L., White, I. J., Shaw, L., Lithgow, J. K., & Foster, S. J. (2002) · Journal of Bacteriology · doi:10.1128/jb.184.19.5457-5467.2002 · Cited by 699
Hsu, S.-T. D., Breukink, E., Tischenko, E., Lutters, M. A. G., de Kruijff, B., Kaptein, R., Bonvin, A. M. J. J., & van Nuland, N. A. J. (2004) · Nature Structural & Molecular Biology · doi:10.1038/nsmb830 · Cited by 547
Resistance of bacterial biofilms to antibiotics a growth-rate related effect?
BROWN, M. R. W., ALLISON, D. G., & GILBERT, P. (1988) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/22.6.777 · Cited by 545
THE STRUCTURE AND MODE OF ACTION OF GLYCOPEPTIDE ANTIBIOTICS OF THE VANCOMYCIN GROUP
Barna, J. C. J., & Williams, D. H. (1984) · Annual Review of Microbiology · doi:10.1146/annurev.mi.38.100184.002011 · Cited by 528
Ruhr, E., & Sahl, H. G. (1985) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.27.5.841 · Cited by 375
Lipid II Is an Intrinsic Component of the Pore Induced by Nisin in Bacterial Membranes
Breukink, E., van Heusden, H. E., Vollmerhaus, P. J., Swiezewska, E., Brunner, L., Walker, S., Heck, A. J. R., & de Kruijff, B. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m301463200 · Cited by 339
Stewart, P. S. (1998) · Biotechnology and Bioengineering · doi:10.1002/(sici)1097-0290(19980805)59:3<261::aid-bit1>3.0.co;2-9 · Cited by 333
Jefferson, K. K., Goldmann, D. A., & Pier, G. B. (2005) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.49.6.2467-2473.2005 · Cited by 319
THE INHIBITING EFFECT OF STREPTOCOCCUS LACTIS ON LACTOBACILLUS BULGARICUS
Rogers, L. A. (1928) · Journal of Bacteriology · doi:10.1128/jb.16.5.321-325.1928 · Cited by 269
Sugimoto, S., Iwamoto, T., Takada, K., Okuda, K.-I., Tajima, A., Iwase, T., & Mizunoe, Y. (2013) · Journal of Bacteriology · doi:10.1128/jb.01672-12 · Cited by 242
Self-citationDispersed mode of Staphylococcus aureus cell wall synthesis in the absence of the division machinery
Pinho, M. G., & Errington, J. (2003) · Molecular Microbiology · doi:10.1046/j.1365-2958.2003.03719.x · Cited by 235
Henrickson, K. J., Axtell, R. A., Hoover, S. M., Kuhn, S. M., Pritchett, J., Kehl, S. C., & Klein, J. P. (2000) · Journal of Clinical Oncology · doi:10.1200/jco.2000.18.6.1269 · Cited by 222
Schwartz, C. L., Henrickson, K. J., Roghmann, K. J., et al. (1990) · Journal of Clinical Oncology · doi:10.1200/jco.1990.8.9.1591 · Cited by 197
Lipid II-Mediated Pore Formation by the Peptide Antibiotic Nisin: a Black Lipid Membrane Study
Wiedemann, I., Benz, R., & Sahl, H.-G. (2004) · Journal of Bacteriology · doi:10.1128/jb.186.10.3259-3261.2004 · Cited by 182
Carratalà, J., Niubó, J., Fernández-Sevilla, A., Juvé, E., Castellsagué, X., Berlanga, J., Liñares, J., & Gudiol, F. (1999) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.43.9.2200 · Cited by 172
Fujita, K., Ichimasa, S., Zendo, T., Koga, S., Yoneyama, F., Nakayama, J., & Sonomoto, K. (2007) · Applied and Environmental Microbiology · doi:10.1128/aem.02286-06 · Cited by 165
Self-citationYoneyama, F., Imura, Y., Ohno, K., Zendo, T., Nakayama, J., Matsuzaki, K., & Sonomoto, K. (2009) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00209-09 · Cited by 154
Self-citationThe biology of lantibiotics from the lacticin 481 group is coming of age
Dufour, A., Hindré, T., Haras, D., & LePennec, J. P. (2006) · FEMS Microbiology Reviews · doi:10.1111/j.1574-6976.2006.00045.x · Cited by 133
Daddi Oubekka, S., Briandet, R., Fontaine-Aupart, M.-P., & Steenkeste, K. (2012) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00216-12 · Cited by 130
Biofilms in Ear, Nose, and Throat Infections: How Important are They?
Vlastarakos, P. V., Nikolopoulos, T. P., Maragoudakis, P., Tzagaroulakis, A., & Ferekidis, E. A. (2007) · The Laryngoscope · doi:10.1097/mlg.0b013e318030e422 · Cited by 119
Demel, R. A., Peelen, T., Siezen, R. J., KRUIJFF, B. D., & Kuipers, O. P. (1996) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1996.00267.x · Cited by 116
Effect of biofilm culture upon the susceptibility of Staphylococcus epidermidis to tobramycin
Duguid, I. G., Evans, E., Brown, M. R., & Gilbert, P. (1992) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/30.6.803 · Cited by 103
Melchior, M. B., Fink‐Gremmels, J., & Gaastra, W. (2006) · Journal of Veterinary Medicine Series B · doi:10.1111/j.1439-0450.2006.00962.x · Cited by 102
Sashihara, T., KIMURA, H., Higuchi, T., Adachi, A., Matsusaki, H., Sonomoto, K., & Ishizaki, A. (2000) · Bioscience Biotechnology and Biochemistry · doi:10.1271/bbb.64.2420 · Cited by 94
Self-citationDuguid, I. G., Evans, E., Brown, M. R., & Gilbert, P. (1992) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/30.6.791 · Cited by 94
Lantibiotics: Insight and foresight for new paradigm
Nagao, J.-I., Asaduzzaman, S. M., Aso, Y., Okuda, K.-I., Nakayama, J., & Sonomoto, K. (2006) · Journal of Bioscience and Bioengineering · doi:10.1263/jbb.102.139 · Cited by 87
Self-citationPag, U., Oedenkoven, M., Papo, N., Oren, Z., Shai, Y., & Sahl, H.-G. (2004) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkh083 · Cited by 82
Ring A of Nukacin ISK-1: A Lipid II-Binding Motif for Type-A(II) Lantibiotic
Islam, M. R., Nishie, M., Nagao, J.-I., Zendo, T., Keller, S., Nakayama, J., Kohda, D., Sahl, H., & Sonomoto, K. (2012) · Journal of the American Chemical Society · doi:10.1021/ja300007h · Cited by 73
Self-citationYoneyama, F., Imura, Y., Ichimasa, S., Fujita, K., Zendo, T., Nakayama, J., Matsuzaki, K., & Sonomoto, K. (2008) · Applied and Environmental Microbiology · doi:10.1128/aem.01827-08 · Cited by 63
Self-citationNukacin ISK-1, a Bacteriostatic Lantibiotic
Asaduzzaman, S. M., Nagao, J.-I., Iida, H., Zendo, T., Nakayama, J., & Sonomoto, K. (2009) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01623-08 · Cited by 54
Self-citationLacticin Q-Mediated Selective Toxicity Depending on Physicochemical Features of Membrane Components
Yoneyama, F., Ohno, K., Imura, Y., Li, M., Zendo, T., Nakayama, J., Matsuzaki, K., & Sonomoto, K. (2011) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00808-10 · Cited by 39
Self-citationLunde, C. S., Rexer, C. H., Hartouni, S. R., Axt, S., & Benton, B. M. (2010) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01609-09 · Cited by 32
Cited by
Bahar, A., & Ren, D. (2013) · Pharmaceuticals · doi:10.3390/ph6121543 · Cited by 1,351
Staphylococcal Biofilm Development: Structure, Regulation, and Treatment Strategies
Schilcher, K., & Horswill, A. R. (2020) · Microbiology and Molecular Biology Reviews · doi:10.1128/mmbr.00026-19 · Cited by 706
Biomedical applications of nisin
Shin, J. M., Gwak, J. W., Kamarajan, P., Fenno, J. C., Rickard, A. H., & Kapila, Y. L. (2016) · Journal of Applied Microbiology · doi:10.1111/jam.13033 · Cited by 607
Novel bacteriocins from lactic acid bacteria (LAB): various structures and applications
Perez, R. H., Zendo, T., & Sonomoto, K. (2014) · Microbial Cell Factories · doi:10.1186/1475-2859-13-s1-s3 · Cited by 575
Self-citationMechanism of Antimicrobial Peptides: Antimicrobial, Anti-Inflammatory and Antibiofilm Activities
Luo, Y., & Song, Y. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms222111401 · Cited by 559
Metadata
- Authors
- Okuda, K.-I., Zendo, T., Sugimoto, S., Iwase, T., Tajima, A., Yamada, S., Sonomoto, K., & Mizunoe, Y.
- Venue
- Antimicrobial Agents and Chemotherapy
- Publisher
- American Society for Microbiology
- Published
- 2013-11
- Volume
- 57
- Issue
- 11
- Pages
- 5572-5579
- ISSN
- 0066-4804 (ISSN-L)
- 1098-6596
- OpenAlex
- W2109427414
- Cited by
- 305
- References
- 40
- FWCI
- 8.35
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.